Willie Earley

Applied Genetics, Inc. Dermatics develops and markets pharmaceutical drugs, skincare ingredients and prestige products. It develops array of cosmetic ingredients to use in skin care products. The company has focused on ingredients for skin protection from environmental damage. The firm also has a topical pharmaceutical product in clinical testing called Dimericine for cancer-prone skin. Applied Genetics was founded by Daniel B Yarosh and Karen Yarosh in May 1985 and is headquartered in Freeport, NY.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Bristol-Myers Squibb Pharma Research Labs LLC researches and develops drugs and related pharmaceutical products. The company is headquartered in San Diego, CA

The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States.

New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY.

Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.

Brany LLC is a private company that has been providing support to sponsors, institutions, and investigators since 1998. The company is based in Lake Success, NY. The company offers IRB and clinical trial solutions that can fill in gaps or enhance existing processes.

The National Medal of Honor Museum Foundation is dedicated to honoring and preserving the history of the highest military decoration awarded for valor in combat. The non-profit company is based in Mount Pleasant, SC. The museum will provide state-of-the-art, interactive experiences and use the stories of Medal of Honor recipients to inspire and motivate Americans to be their best selves. The foundation will also establish a national monument in the nation's capital to commemorate the service and sacrifice of the bravest and most decorated members of the armed forces. The CEO of the company is Joe Daniels.

Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA.

The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky.

LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA.

Embody, Inc. designs, develops, and distributes implantable medical devices. The company was founded by Jeff Conroy and Michael Francis and is headquartered in Norfolk, VA.

AltPep Corp. operates as a biotechnology company that provides platform for tackling amyloid diseases: early diagnostics, disease-modifying therapeutics, and anti-biofilm treatments. The company was founded by Valerie Daggett and Michael Mullan and is headquartered in Mercer Island, WA.

Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach.

Alexandria Agtech/Climate Innovation Acquisition Corp. operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 18, 2021 and is headquartered in Pasadena, CA.

Advisor Partners II LLC (Advisor Partners) is a SEC-registered investment advisor and wealth management firm headquartered in Walnut Creek, California. The firm is related to Pathstone Family Office LLC (Pathstone) as a result of common control and ownership. Pathstone is a multi-family office investment advisory practice owned by Pathstone Holdings LLC. Advisor Partners provides discretionary investment advisory, sub-advisory and consulting services primarily to clients of registered investment advisers (RIA) and financial institutions through two distinct investment programs: Separately Managed Accounts (SMA) and Model Portfolio Consulting (MPC).

Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland.